Inventory, Net in USD of Eiger BioPharmaceuticals, Inc. from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Inventory, Net history and change rate from Q4 2020 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Inventory, Net for the quarter ending 31 Dec 2023 was $1.56M, a 45.5% decline year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.56M -$1.3M -45.5% 31 Dec 2023 10-K 08 Apr 2024
Q3 2023 $1.11M -$1.71M -60.8% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $1.1M -$1.78M -61.8% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $5.34M +$3.43M +179% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $2.85M +$241K +9.23% 31 Dec 2022 10-K 08 Apr 2024
Q3 2022 $2.82M +$196K +7.48% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $2.88M +$811K +39.3% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $1.91M +$513K +36.7% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $2.61M +$2.52M +2709% 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $2.62M 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $2.07M 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $1.4M 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $93K 31 Dec 2020 10-K 10 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.